Articles about Pfizer

Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'

20 Sep 2021

Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'

The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children ages 5 to 11 years old and generates a "robust" immune response, the companies said Monday.

England school children aged 12-15yrs to be offered COVID-19 vaccine

14 Sep 2021

England school children aged 12-15yrs to be offered COVID-19 vaccine

School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.

COVID-19 vaccines for younger kids could be available from October

13 Sep 2021

COVID-19 vaccines for younger kids could be available from October

Amid surging Delta variant cases in the USA, COVID-19 vaccines for children younger than 12 years could be available by the end of next month, a media report has said.

No serious vaccine side effects in breastfeeding moms, infants: Study

09 Sep 2021

No serious vaccine side effects in breastfeeding moms, infants: Study

Breastfeeding mothers vaccinated with Pfizer or Moderna preventive experienced similar side effects to what have previously been reported in non-breastfeeding women, while infants exhibited no adverse events after immunization, a study has found.

80% immunity from Pfizer vaccine lost in 6 months: Study

06 Sep 2021

80% immunity from Pfizer vaccine lost in 6 months: Study

COVID-19 antibodies generated by the Pfizer vaccine dipped by more than 80% six months after the second dose, a study conducted in the United States has found.

US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA

23 Aug 2021

US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA

The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.

Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week

21 Aug 2021

Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week

The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.

Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study

19 Aug 2021

Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study

COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.

No sign of Pfizer, Moderna vaccines in breast milk: Study

20 Jul 2021

No sign of Pfizer, Moderna vaccines in breast milk: Study

Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.

Pfizer COVID-19 vaccine induces good immune response against coronavirus variants

05 Jul 2021

Pfizer COVID-19 vaccine induces good immune response against coronavirus variants

Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.

Mix-and-match COVID-19 vaccines: What do studies say?

02 Jul 2021

Mix-and-match COVID-19 vaccines: What do studies say?

In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.

Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

24 Jun 2021

Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

Pfizer, AstraZeneca vaccines protect against Delta variant, says study

15 Jun 2021

Pfizer, AstraZeneca vaccines protect against Delta variant, says study

Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.

How does India plan to vaccinate children against coronavirus?

14 Jun 2021

How does India plan to vaccinate children against coronavirus?

The Indian government wants to soon start inoculating children against the coronavirus. However, there is no vaccine for that group yet.

US will distribute 500M Pfizer vaccine doses to 100 countries

10 Jun 2021

US will distribute 500M Pfizer vaccine doses to 100 countries

The United States is buying 500 million doses of the Pfizer coronavirus vaccine to donate them among nearly 100 countries by the next year, top American newspapers have reported.

When will the COVID-19 vaccine for children be ready?

10 Jun 2021

When will the COVID-19 vaccine for children be ready?

India does not have a coronavirus vaccine for children as yet.

'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15

04 Jun 2021

'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15

The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years.

After Pfizer and Moderna, Serum seeks indemnity over COVID-19 vaccine

03 Jun 2021

After Pfizer and Moderna, Serum seeks indemnity over COVID-19 vaccine

The Serum Institute of India has requested the Indian government to provide it indemnity from liability in connection with its COVID-19 vaccines, company sources cited by NDTV and The Hindu say.

Most COVID-19 vaccines might offer lasting protection: Study

03 Jun 2021

Most COVID-19 vaccines might offer lasting protection: Study

The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.

Israel finds possible link between Pfizer vaccine and heart inflammation

02 Jun 2021

Israel finds possible link between Pfizer vaccine and heart inflammation

Israel has flagged a possible link between the COVID-19 vaccine developed by Pfizer-BioNTech and cases of heart inflammation (myocarditis), observed mainly in young men.

Foreign COVID-19 vaccines exempted from local trials, batch testing

02 Jun 2021

Foreign COVID-19 vaccines exempted from local trials, batch testing

The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.

India should procure Pfizer's COVID-19 vaccine for children: Kejriwal

27 May 2021

India should procure Pfizer's COVID-19 vaccine for children: Kejriwal

Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer COVID-19 vaccine as soon as possible to inoculate children.

Pfizer's vaccine works against B.1.617 variant, firm tells Indian government

27 May 2021

Pfizer's vaccine works against B.1.617 variant, firm tells Indian government

Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.

India may not receive Pfizer, Moderna vaccine doses until 2023

25 May 2021

India may not receive Pfizer, Moderna vaccine doses until 2023

India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.

Pfizer, Moderna have refused to sell vaccines directly to Delhi

24 May 2021

Pfizer, Moderna have refused to sell vaccines directly to Delhi

American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.

Delayed second Pfizer shot boosts immunity by over three times

21 May 2021

Delayed second Pfizer shot boosts immunity by over three times

Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.

India may buy 50mn Pfizer COVID-19 vaccine doses: Details here

15 May 2021

India may buy 50mn Pfizer COVID-19 vaccine doses: Details here

At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.

Americans can finally ditch the mask, says CDC

14 May 2021

Americans can finally ditch the mask, says CDC

In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

11 May 2021

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

US expands Pfizer COVID-19 shot to children 12 and above

11 May 2021

US expands Pfizer COVID-19 shot to children 12 and above

COVID-19 vaccines finally are headed for more kids as US regulators on Monday expanded the use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class.

Pfizer in talks with India for expedited approval for vaccine

03 May 2021

Pfizer in talks with India for expedited approval for vaccine

United States pharmaceutical major Pfizer is in talks with the Indian government to seek expedited approval for its COVID-19 vaccine.

Pfizer will supply COVID-19 vaccine only through government channels

22 Apr 2021

Pfizer will supply COVID-19 vaccine only through government channels

Pharmaceutical giant Pfizer will supply its coronavirus vaccine only through government channels in India, The Indian Express reported today.

Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study

30 Mar 2021

Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study

The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.

Pfizer-BioNTech's coronavirus vaccine being tested on children under 12

26 Mar 2021

Pfizer-BioNTech's coronavirus vaccine being tested on children under 12

American pharma giant Pfizer and German company BioNTech began testing their coronavirus vaccine on children, aged under 12, reports Reuters.

Hong Kong suspends Pfizer vaccines over packaging defects

24 Mar 2021

Hong Kong suspends Pfizer vaccines over packaging defects

Hong Kong suspended vaccinations using Pfizer-BioNTech COVID-19 shots in the city on Wednesday after they were informed by its distributor Fosun that one batch had defective bottle lids.

Pfizer-BioNTech to give EU another 200 million COVID-19 shots

17 Feb 2021

Pfizer-BioNTech to give EU another 200 million COVID-19 shots

Pfizer and BioNTech, on Wednesday, finalized an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.

Expert panel recommended against granting EUA to Pfizer's vaccine: Officials

05 Feb 2021

Expert panel recommended against granting EUA to Pfizer's vaccine: Officials

Just two days before pharma major Pfizer announced the withdrawal of its application for emergency use authorization of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage.

UK begins world's first alternate dosing COVID-19 vaccine trial

04 Feb 2021

UK begins world's first alternate dosing COVID-19 vaccine trial

Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.

Recovered COVID-19 patients need only one shot of mRNA vaccines

04 Feb 2021

Recovered COVID-19 patients need only one shot of mRNA vaccines

People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.

Russia's coronavirus vaccine approved for use in Mexico

03 Feb 2021

Russia's coronavirus vaccine approved for use in Mexico

Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.